In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

Oil-in-water nanoemulsions (NEs) represent one of the formulation approaches to improve eye-related bio-availability of lipophilic drugs. The potential of cationic NEs is pronounced due to the electrostatic interaction of positively charged droplets with negatively charged mucins present in the tear...

Full description

Saved in:
Bibliographic Details
Main Authors: Dukovski Bisera Jurišić, Bračko Ana, Šare Marija, Pepić Ivan, Lovrić Jasmina
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2019-0054
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572217411502080
author Dukovski Bisera Jurišić
Bračko Ana
Šare Marija
Pepić Ivan
Lovrić Jasmina
author_facet Dukovski Bisera Jurišić
Bračko Ana
Šare Marija
Pepić Ivan
Lovrić Jasmina
author_sort Dukovski Bisera Jurišić
collection DOAJ
description Oil-in-water nanoemulsions (NEs) represent one of the formulation approaches to improve eye-related bio-availability of lipophilic drugs. The potential of cationic NEs is pronounced due to the electrostatic interaction of positively charged droplets with negatively charged mucins present in the tear film, providing prolonged formulation residence at the ocular surface. The aim of this study was to develop a cationic ophthalmic NE with cationic lipid stearylamine (SA) as a carrier of a positive charge. The addition of a nonionic surfactant provided the dual electro-steric stabilization of NEs and enabled tuning of SA concentration to achieve an optimal balance between its interaction with mucins and biocompatibility. Physicochemical characterization, stability profile, in vitro mucoadhesion study and biocompatibility study employing 3D HCE-T cell-based model of corneal epithelium pointed out the NE with 0.05 % (m/m) SA as the leading formulation. Minimizing SA content while retaining droplet/mucin interactions is of great importance for efficacy and safety of future ophthalmic drug products.
format Article
id doaj-art-912bc061b015423d90381c9dd5221a76
institution Kabale University
issn 1846-9558
language English
publishDate 2019-12-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-912bc061b015423d90381c9dd5221a762025-02-02T11:25:09ZengSciendoActa Pharmaceutica1846-95582019-12-0169462163410.2478/acph-2019-0054acph-2019-0054In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug deliveryDukovski Bisera Jurišić0Bračko Ana1Šare Marija2Pepić Ivan3Lovrić Jasmina4University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, HR-10000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, HR-10000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, HR-10000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, HR-10000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, HR-10000Zagreb, CroatiaOil-in-water nanoemulsions (NEs) represent one of the formulation approaches to improve eye-related bio-availability of lipophilic drugs. The potential of cationic NEs is pronounced due to the electrostatic interaction of positively charged droplets with negatively charged mucins present in the tear film, providing prolonged formulation residence at the ocular surface. The aim of this study was to develop a cationic ophthalmic NE with cationic lipid stearylamine (SA) as a carrier of a positive charge. The addition of a nonionic surfactant provided the dual electro-steric stabilization of NEs and enabled tuning of SA concentration to achieve an optimal balance between its interaction with mucins and biocompatibility. Physicochemical characterization, stability profile, in vitro mucoadhesion study and biocompatibility study employing 3D HCE-T cell-based model of corneal epithelium pointed out the NE with 0.05 % (m/m) SA as the leading formulation. Minimizing SA content while retaining droplet/mucin interactions is of great importance for efficacy and safety of future ophthalmic drug products.https://doi.org/10.2478/acph-2019-0054cationic nanoemulsionsstearylamineophthalmic drug deliverybiocompatibilitymucoadhesion in vitro
spellingShingle Dukovski Bisera Jurišić
Bračko Ana
Šare Marija
Pepić Ivan
Lovrić Jasmina
In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
Acta Pharmaceutica
cationic nanoemulsions
stearylamine
ophthalmic drug delivery
biocompatibility
mucoadhesion in vitro
title In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
title_full In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
title_fullStr In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
title_full_unstemmed In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
title_short In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
title_sort in vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
topic cationic nanoemulsions
stearylamine
ophthalmic drug delivery
biocompatibility
mucoadhesion in vitro
url https://doi.org/10.2478/acph-2019-0054
work_keys_str_mv AT dukovskibiserajurisic invitroevaluationofstearylaminecationicnanoemulsionsforimprovedoculardrugdelivery
AT brackoana invitroevaluationofstearylaminecationicnanoemulsionsforimprovedoculardrugdelivery
AT saremarija invitroevaluationofstearylaminecationicnanoemulsionsforimprovedoculardrugdelivery
AT pepicivan invitroevaluationofstearylaminecationicnanoemulsionsforimprovedoculardrugdelivery
AT lovricjasmina invitroevaluationofstearylaminecationicnanoemulsionsforimprovedoculardrugdelivery